Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction

Although most current treatments for autoimmunity involve broad immunosuppression, recent efforts have aimed to suppress T cells in an antigen-specific manner to minimize risk of infection. One such effort is through targeting antigen to the apoptotic pathway to increase presentation of the antigen of interest in a tolerogenic context. Erythrocytes present a rational candidate to target because of their high rate of eryptosis, which facilitates continual uptake by antigen-presenting cells in the spleen. Here, we develop an approach that binds antigens to erythrocytes to induce sustained T cell dysfunction. Transcriptomic and phenotypic analyses revealed signatures of self-tolerance and exhaustion, including up-regulation of PD-1, CTLA4, Lag3, and TOX. Antigen-specific T cells were incapable of responding to an adjuvanted antigenic challenge even months after antigen clearance. With this strategy, we prevented pathology in a mouse experimental autoimmune encephalomyelitis model. CD8(+) T cell education occurred in the spleen and was dependent on cross-presenting Batf3(+) dendritic cells. These results demonstrate that antigens associated with eryptotic erythrocytes induce lasting T cell dysfunction that could be protective in deactivating pathogenic T cells.

Automated summary

In this study, antigens bound to eryptotic erythrocytes induced sustained T cell dysfunction, leading to self-tolerance and exhaustion. By targeting antigens associated with eryptotic erythrocytes, the researchers were able to prevent pathology in a mouse experimental autoimmune encephalomyelitis model.